Quanterix Corporation QTRX 深 滬
已收盤 02-06 16:00:00 美东时间
6.09
+0.210
+3.57%
華盛通- 最 高6.205
- 今 開5.97
- 成交量 56.73万股
- 最 低 5.77
- 昨 收 5.88
- 總市值 2.84亿
- 52周最高 8.77
- 市盈率 靜 --
- 換手率 1.21%
- 52周最低 4.05
- 委 比 89.47%
- 總股本 4671.08万
- 歷史最高 92.57
- 量 比 0.82
- 振 幅 7.40%
- 歷史最低 4.05
- 每 手 1
- 風險率 1.01%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Quanterix Submits 510(k) Premarket Notification to FDA For Multi-Analyte Algorithmic Blood Test For Alzheimer's Disease
The multi-analyte test previously received Breakthrough Device Designation from the FDA, a program intended to accelerate the development and review of devices that provide for more effective treatment or diagnosis of
02-03 21:37
Quanterix Submits FDA 510(k) Application for Multi-Analyte Blood Test for Alzheimer's Detection
Quanterix Submits FDA 510(k) Application for Multi-Analyte Blood Test for Alzheimer's Detection Quanterix Corporation has announced the submission of a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its multi-analyte algorithmic blood test designed for Alzheimer's d
02-03 21:33
JAMA Network Open Publishes Quanterix Study Showing Multi-Biomarker Model Predicts Early Alzheimer's Progression; The Optimal Model Achieved A C-Index Of 0.90 For Identifying Individuals With SCD
Analysis of Subjective Cognitive Decline (SCD) cohort indicates that combining biomarkers representing four key biological axes—amyloid, tau, neurodegeneration, and neuroinflammation—provides a superior window into
01-21 21:38
Quanterix Unveils Landmark Study Showing Multi-Biomarker Blood Test Improves Early Alzheimer’s Risk Profiling
Quanterix Unveils Landmark Study Showing Multi-Biomarker Blood Test Improves Early Alzheimer’s Risk Profiling Quanterix Corporation has announced the publication of a new clinical study in JAMA Network Open, led by researchers at Amsterdam UMC, which followed a cohort of nearly 300 individuals for u
01-21 21:33
Illumina names former NIH official as medical chief; commercial chief joins Quanterix
Illumina (ILMN) shares fell on Friday after its chief commercial officer, Everett Cunningham, resigned to lead the rival life sciences company Quanterix (QTRX), while former NIH genomics director Eric...
01-10 00:51
CG Oncology, Rich Sparkle Holdings, Liquidia And Other Big Stocks Moving Higher On Friday
U.S. stocks were higher, with the Dow Jones index gaining around 200 points on ...
01-10 00:25
Quanterix gains on CEO change, revenue guidance (update)
Update: Includes share move, guidance commentary Quanterix (QTRX) shares surged 25% Friday after the company announced a CEO transition alongside an upbeat update indicating it expects to exceed its f...
01-09 23:05
Quanterix Announces CEO Transition to Drive Growth
Quanterix ( ($QTRX) ) has provided an update. On January 8, 2026, Quanterix ann...
01-09 06:19
Quanterix Appoints Everett Cunningham President, CEO, Effective Jan. 19
Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that its Board of Directors
01-09 05:33
美股大行评级 | 潜在涨幅498.16%！SurgePays Inc获Ascendiant Capital升目标价至9.75美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持SurgePays Inc"买入"评级，目标价从9.5美元升至9.75美元；Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从8美元升至10美元
2025-12-23 12:32
